June 7, 2022 C-Path and MitoAction Announce Data Sharing Agreement to Support Treatment Development in Mitochondrial Disease TUCSON, Ariz., June 7, 2022 — Critical Path Institute (C-Path) and MitoAction today announced a joint collaboration to incorpora
xCures joins C-Path’s Cure Drug Repurposing Collaboratory to Deliver AI-enabled Data Abstraction of Health Records Members of CDRC will be able to utilize xCures’ technology to quickly abstract and structure clinical data to support drug repur
Biochemist, Biotechnology Expert to Lead C-Path’s Type 1 Diabetes Consortium TUCSON, Ariz., June 2, 2022 — Critical Path Institute (C-Path) has named Elnaz Atabakhsh, Ph.D., as Executive Director of its Ty
C-Path Receives Largest Data Transfer to Date from UK’s National Neonatal Research Database The EPR data transfer is the first from the United Kingdom and includes data from nearly 200 hospitals TUCSON, Ariz., June
FSHD Society and Critical Path Institute Collaborate to Collect Clinical Trial Data TUCSON, Ariz., May 23, 2022 — The FSHD Society, a research-focused patient advocacy nonprofit dedicated to bringing treatments
C-Path to Lead Novel Pre-Consortium Framework for Optimizing the Rare and Orphan Medical Product Lifecycle TUCSON, Ariz., April 28, 2022 — Critical Path Institute (C-Path), in collaboration with one of the industry’s prominent r
Longtime Pharmaceutical Executive to Lead C-Path’s Sickle Cell Disease Consortium TUCSON, Ariz., April 14, 2022 – Critical Path Institute (C-Path) has named Sergey Rakhilin, Ph.D., as Executive Director of its
C-Path Receives Qualification Opinion from EMA on Type 1 Diabetes Biomarker Initiative TUCSON, Ariz., April 5, 2022 — Critical Path Institute’s (C-Path) Type 1 Diabetes Consortium (T1DC) today announced that the E
C-Path European Nonprofit Established in Amsterdam C-Path in Europe works seamlessly with its U.S. counterpart to advance the development of novel regulatory-endorsed methodologies
C-Path and Tufts Medical Center Collaborate on EHR Data Transfer The endeavor represents a major milestone for C-Path TUCSON, Ariz., March 10, 2022 — Critical Path Institute (C-Path) and